CASR and malignant colon neoplasm: Here, we used 1 μmol/L of each compound, as the initial results using NPS R-568 and NPS R-2143 in these transfected colon cancer cells were obtained using drug concentrations that were previously deemed to be CaSR-selective [5,9,14,15,16].